Neogen (NEOG) EPS (Basic) Growth (3y) (2013 - 2026)
Neogen (NEOG) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.90 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 126.12 Bn | 122.64 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 118.45 Bn | 109.23 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 73.30 Bn | 72.77 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 51.60 Bn | 47.35 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.52 Bn | 32.57 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 33.71 Bn | 31.60 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.14 Bn | 22.82 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.13 Bn | 22.65 Bn | 684.20 Mn | 17.98% |
| 10 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | -126.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -126.28% |
| Feb 28, 2026 | -59.55% |
| Nov 30, 2025 | 27.67% |
| Aug 31, 2025 | 51.30% |
| May 31, 2025 | -191.43% |
| Feb 28, 2025 | -44.14% |
| Nov 30, 2024 | -184.06% |
| Aug 31, 2024 | -33.26% |
| May 31, 2024 | -29.78% |
| Feb 29, 2024 | -27.54% |
| Nov 30, 2023 | -28.22% |
| Aug 31, 2023 | -64.06% |
| May 31, 2023 | -39.89% |
| Feb 28, 2023 | -31.05% |
| Nov 30, 2022 | -48.13% |
| Aug 31, 2022 | -29.88% |
| May 31, 2022 | -4.67% |
| Feb 28, 2022 | -26.19% |
| Nov 30, 2021 | -13.29% |
| Aug 31, 2021 | 2.61% |